Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 91 days ( -2.26 % )
Last Price $19.00 0 %
High/ Low $19.00 - $19.00 0%
Chg 7 Days N/A $19.00 $19.00
Chg 30 Days N/A $19.00 $19.00
Chg 12 mos -8.03 % $20.66 $19.00
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 15.58 % Width: 107.20 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $13.19 - $27.34 -30.56 % - 43.88 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2023-09-25 - 93 days
Long MA avg 12 mos Buy 2023-09-25 - 93 days
Short/Long MA avg 12 mos Buy 2023-09-26 - 92 days
Pivot Short Sell 2024-02-05 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Intercept Pharmaceuticals

Intercept Pharmaceuticals Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona... ICPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT